News ASP Isotopes Inc.

Equities

ASPI

US00218A1051

Pharmaceuticals

Real-time Estimate Cboe BZX Other stock markets 04:23:11 2026-01-22 pm EST			5-day change	1st Jan Change
8.260 ^USD	+13.15%		+2.96%	+36.45%

Jan. 12	ASP Isotopes Inc. Announces Executive Appointments	CI
Jan. 07	ASP Isotopes Inc. completed the acquisition of Renergen Limited from Mazi Asset Management Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital Ltd., Ivy Asset Management LLC, Ye Jia and others.	CI

Jan. 12	ASP Isotopes Inc. Announces Executive Appointments	CI
Jan. 07	ASP Isotopes Inc. completed the acquisition of Renergen Limited from Mazi Asset Management Ltd, Matc Investments Pty Ltd, CRT investments Pty. Ltd., Anchor Capital Ltd., Ivy Asset Management LLC, Ye Jia and others.	CI
Jan. 07	Asp Isotopes closes acquisition of Renergen	RE
Jan. 07	ASP Isotopes Closes Acquisition of Renergen	GL
Dec. 30	ASX Midday Sector Update: Energy Stocks Climb, Real Estate Struggles	MT
Dec. 30	Renergen Securities Suspended From Quotation	MT
Dec. 17	Renergen, ASP Isotopes' Scheme of Arrangement Now Unconditional	MT
Dec. 17	ASP Isotopes Receives All Regulatory Approvals for Acquisition of Renergen	MT
Dec. 17	ASP Isotopes Inc. Announces Receipt of Regulatory Approvals for Acquisition of Renergen Limited	GL
Dec. 14	Certain Warrants of ASP Isotopes Inc. are subject to a Lock-Up Agreement Ending on 15-DEC-2025.	CI
Dec. 14	Certain Options of ASP Isotopes Inc. are subject to a Lock-Up Agreement Ending on 15-DEC-2025.	CI
Dec. 14	Certain Common Stock of ASP Isotopes Inc. are subject to a Lock-Up Agreement Ending on 15-DEC-2025.	CI
Dec. 02	Asp Isotopes Inc. Announces That Paul Mann to Return from Temporary Leave of Absence as Executive Chairman	CI
Dec. 02	Asp Isotopes Inc. Announces Paul Mann to Return from Temporary Leave of Absence as Chief Executive Officer, Effective January 19, 2026	CI
Dec. 02	ASP Isotopes Says Paul Mann to Resume CEO Role in January	MT
Dec. 02	Asp Isotopes Inc. announces Paul Mann to return from temporary leave of absence as executive chairman and CEO	RE
Dec. 02	ASP Isotopes Inc. Announces Paul Mann to Return from Temporary Leave of Absence as Executive Chairman and Chief Executive Officer	GL
Nov. 28	Asp Isotopes Inc - on Nov 27, extended date for Renergen acquisition offer conditions - SEC filing	RE
Nov. 28	ASP Isotopes Announces Endowment of New Photonics Chair at Wits University to Advance Photonics Research	GL
Nov. 28	ASP Isotopes Announces Endowment of New Photonics Chair at Wits University to Advance Photonics Research	AQ
Nov. 28	ASP Isotopes Extends Deadline to Meet Closing Conditions for Renergen Acquisition	MT
Nov. 21	ASP Isotopes : Q3 Investor Update (ASPI Q3 Update Call presentation)	PU
Nov. 19	ASP Isotopes Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Nov. 17	ASP Isotopes to Provide Quarterly Business Update Call on November 21, 2025 at 8:30am EST	GL
Nov. 14	Certain Common Stock of ASP Isotopes Inc. are subject to a Lock-Up Agreement Ending on 15-NOV-2025.	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

News ASP Isotopes Inc.

Equities

ASPI

US00218A1051

Pharmaceuticals

Filters